Apogen Biotechnologies, a US-based oncological therapy spinout of University of Minnesota, boosted its series A round to $11m yesterday with a $4m extension from investors including pharmaceutical firm Merck Group.
Merck contributed to the capital through its corporate venturing subsidiary M Ventures, and was joined by unnamed, existing investors.
Apogen previously raised an initial $7m tranche in 2016 from WRF Capital, the investment arm of commercialisation firm Washington Research Foundation, Arch Venture Partners and Accelerator Life Science Partners.
AbbVie Ventures and Johnson & Johnson Innovation – JJDC, respective corporate venturing units for drug developers AbbVie and Johnson & Johnson, also backed the first close, as did pharmaceutical firms Eli Lilly and Wuxi AppTec’s corporate venture fund.
Alexandria Venture Investments, a subsidiary of real estate developer Alexandria Real Estate Equities, and Watson Fund also took part.
Founded in 2014, Apogen is working on medications that…
Apogen regenerates series A
Aug 24, 2018 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
University of Notre Dame tries new, supersized approach to creating spinouts
University of Notre Dame tries new, supersized approach to creating spinouts
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
How Basel supercharged its spinout rate
How Basel supercharged its spinout rate
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg